BACKGROUND: Morbid obesity affects the pharmacokinetics and pharmacodynamics of anesthetics, which may result in inappropriate dosing. We hypothesized that obesity significantly alters the minimum alveolar concentration (MAC) for isoflurane and sevoflurane. To test this hypothesis, we used a rodent model of human metabolic syndrome developed through artificial selection for inherent low aerobic capacity runners (LCR) and high aerobic capacity runners (HCR). The LCR rats are obese, display phenotypes homologous to those characteristic of human metabolic syndrome, and exhibit low running endurance. In contrast, HCR rats have high running endurance and are characterized by improved cardiovascular performance and overall health. METHODS: Male and female LCR (n = 10) and HCR (n = 10) rats were endotracheally intubated and maintained on mechanical ventilation with either isoflurane or sevoflurane. A bracketing design was used to determine MAC; sensory stimulation was induced by tail clamping. An equilibration period of 30 minutes was provided before and between the consecutive tail clamps. Two-tailed parametric (unpaired t test) and nonparametric (Mann-Whitney test) statistics were used for the comparison of MAC between LCR and HCR rats. The data are reported as mean ± sd along with the 95% confidence interval. A P value of <0.05 was considered statistically significant. RESULTS: The MAC for isoflurane in LCR rats (1.52% ± 0.13%) was similar to previously reported isoflurane-MAC for normal rats (1.51% ± 0.12%). The HCR rats showed a significantly higher isoflurane-MAC (1.90% ± 0.19%) than did the LCR rats (1.52% ± 0.13%) (P = 0.0001). The MAC for sevoflurane was not significantly different between LCR and HCR rats and was similar to the previously published sevoflurane-MAC for normal rats (2.4% ± 0.30%). There was no influence of sex on the MAC of either isoflurane or sevoflurane. CONCLUSION: Obesity and associated comorbidities do not affect anesthetic requirements as measured by MAC in a rodent model of metabolic syndrome. By contrast, high aerobic capacity is associated with a higher MAC for isoflurane and may be a risk factor for subtherapeutic dosing.
BACKGROUND: Morbid obesity affects the pharmacokinetics and pharmacodynamics of anesthetics, which may result in inappropriate dosing. We hypothesized that obesity significantly alters the minimum alveolar concentration (MAC) for isoflurane and sevoflurane. To test this hypothesis, we used a rodent model of humanmetabolic syndrome developed through artificial selection for inherent low aerobic capacity runners (LCR) and high aerobic capacity runners (HCR). The LCR rats are obese, display phenotypes homologous to those characteristic of humanmetabolic syndrome, and exhibit low running endurance. In contrast, HCRrats have high running endurance and are characterized by improved cardiovascular performance and overall health. METHODS: Male and female LCR (n = 10) and HCR (n = 10) rats were endotracheally intubated and maintained on mechanical ventilation with either isoflurane or sevoflurane. A bracketing design was used to determine MAC; sensory stimulation was induced by tail clamping. An equilibration period of 30 minutes was provided before and between the consecutive tail clamps. Two-tailed parametric (unpaired t test) and nonparametric (Mann-Whitney test) statistics were used for the comparison of MAC between LCR and HCRrats. The data are reported as mean ± sd along with the 95% confidence interval. A P value of <0.05 was considered statistically significant. RESULTS: The MAC for isoflurane in LCR rats (1.52% ± 0.13%) was similar to previously reported isoflurane-MAC for normal rats (1.51% ± 0.12%). The HCRrats showed a significantly higher isoflurane-MAC (1.90% ± 0.19%) than did the LCR rats (1.52% ± 0.13%) (P = 0.0001). The MAC for sevoflurane was not significantly different between LCR and HCRrats and was similar to the previously published sevoflurane-MAC for normal rats (2.4% ± 0.30%). There was no influence of sex on the MAC of either isoflurane or sevoflurane. CONCLUSION:Obesity and associated comorbidities do not affect anesthetic requirements as measured by MAC in a rodent model of metabolic syndrome. By contrast, high aerobic capacity is associated with a higher MAC for isoflurane and may be a risk factor for subtherapeutic dosing.
Authors: Ulrik Wisløff; Sonia M Najjar; Oyvind Ellingsen; Per Magnus Haram; Steven Swoap; Qusai Al-Share; Mats Fernström; Khadijeh Rezaei; Sang Jun Lee; Lauren Gerard Koch; Steven L Britton Journal: Science Date: 2005-01-21 Impact factor: 47.728
Authors: Norberto C Gonzalez; Scott D Kirkton; Richard A Howlett; Steven L Britton; Lauren G Koch; Harrieth E Wagner; Peter D Wagner Journal: J Appl Physiol (1985) Date: 2006-06-15
Authors: Scott D Kirkton; Richard A Howlett; Norberto C Gonzalez; Patrick G Giuliano; Steven L Britton; Lauren G Koch; Harrieth E Wagner; Peter D Wagner Journal: J Appl Physiol (1985) Date: 2009-03-19
Authors: Michael S Avidan; Lini Zhang; Beth A Burnside; Kevin J Finkel; Adam C Searleman; Jacqueline A Selvidge; Leif Saager; Michelle S Turner; Srikar Rao; Michael Bottros; Charles Hantler; Eric Jacobsohn; Alex S Evers Journal: N Engl J Med Date: 2008-03-13 Impact factor: 91.245
Authors: Michael E Geisser; Wenfei Wang; Matthew Smuck; Lauren G Koch; Steven L Britton; Ralph Lydic Journal: Neurosci Lett Date: 2008-07-19 Impact factor: 3.046
Authors: William A Filbey; David T Sanford; Helen A Baghdoyan; Lauren G Koch; Steven L Britton; Ralph Lydic Journal: Sleep Date: 2014-05-01 Impact factor: 5.849
Authors: Christopher G Sinon; Amy Ottensmeyer; Austin N Slone; Dan C Li; Rachael S Allen; Machelle T Pardue; Paul S García Journal: Neurosci Lett Date: 2021-03-08 Impact factor: 3.046
Authors: Viviane S Hambrecht-Wiedbusch; Katherine A LaTendresse; Michael S Avidan; Amanda G Nelson; Margaret Phyle; Romi E Ajluni; George A Mashour Journal: Front Behav Neurosci Date: 2019-04-17 Impact factor: 3.558